LHDX News and Press, Lucira Health Inc. From 12/27/21

The number of new daily COVID-19 cases across the country  is now the highest it has been since January. Cases began accelerating in October 2020 thanks to the introduction of the Delta variant, with that variant peaking in January 2021, according to CDC data. The latest data shows that ...

The extremely highly demand for at-home COVID-19 tests in the face of the rising number of cases is causing a spike in the share price of some test makers. Cue Health (HLTH +12.3%), Lucira Health (LHDX +13.6%), and Fulgent Genetics (FLGT +4.8%) are the three with the biggest gains today. Quid...

Gainers: Microbot Medical (NASDAQ:MBOT) +51%, CollPlant Biotechnologies (NASDAQ:CLGN) +27%, Lucira Health (NASDAQ:LHDX) +14%, IceCure Medical (NASDAQ:ICCM) +13%, Cue Health (NASDAQ:HLTH) +12%. Losers: BridgeBio Pharma (NASDAQ:BBIO) -71%, Biond...

Lucira's tests are the only available at-home self-test kits that deliver PCR-quality accuracy and early detectability in a single-use test kit with results in 30 minutes Current surge of COVID-19 cases caused by the Omicron variant highlights the need for additional at-home tes...

Fourth vaccine: Israel is set to become the first country in the world to administer a fourth COVID-19 vaccine, which would give "greater protection in the face of Omicron." The first eligible group to receive the vaccine will be people age 60 and older, as well as the immunocompromised and m...

President Biden this afternoon said that the country is "not going back to March 2020" when lockdowns became the norm at the start of the COVID-19 pandemic despite a surge in cases. At a White House press conference, Biden said now "we're prepared and we know more. We just have to stay focuse...

Private health insurers will be required to cover at-home COVID-19 tests, President Joe Biden is expected to announce today, Reuters reports. Plan members could get reimbursed for over-the-counter tests, according to administration officials. The change comes in the face of the first case of ...

Lucira assessment confirms COVID-19 Check-It (OTC) and All-In-One (Rx) molecular self-test kits' ability to detect 100% of Omicron variant genome sequences analyzed Lucira assays target viral sequence regions unaffected by the spike protein mutations found in Omicron, Delta an...

Image source: The Motley Fool. Lucira Health, Inc. (NASDAQ: LHDX) Q3 2021 Earnings Call Nov 11, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Lucira Health, Inc. (LHDX) Q3 2021 Earnings Call Transcript

Lucira Health, Inc. (LHDX) Q3 2021 Earnings Conference Call November 11, 2021 4:30 PM ET Company Participants Greg Chodaczek – Investor Relations Erik Engelson – President and Chief Executive Officer Dan George – Chief Financial Officer Conference Call Participants Derik ...